Biogen Inc (BUE:BIIB)
ARS 18636 201.5 (1.09%) Market Cap: 28.98 Til Enterprise Value: 34.17 Til PE Ratio: 27.95 PB Ratio: 2.13 GF Score: 53/100

Biogen Inc Annual Shareholders Meeting Transcript

Jun 02, 2021 / 01:00PM GMT
Release Date Price: ARS3485 (+1.56%)
Operator

Welcome to the Annual Meeting for Biogen Inc. Our host for today's call is Dr. Stelios Papadopoulos, Chairman of the Board. (Operator Instructions)

I will now turn the call over to your host, Dr. Papadopoulos, You may begin.

Stelios Papadopoulos
Biogen Inc. - Independent Chairman of the Board

Thank you, sir. Good morning. I'm Stelios Papadopoulos, Chairman of the Board of Biogen, I would like to welcome you to Biogen's 2021 Annual Meeting of Stockholders.

I'm here today with Susan Alexander, Biogen's Chief Legal Officer and Corporate Secretary, who will act as Secretary of the meeting; and Michel Vounatsos, our Chief Executive Officer and a Director, who will make a company presentation following the conclusion of the formal portion of the meeting.

I am also joined by each of the other members of our Board of Directors, and I will name them later as well as members of the executive team of Biogen, including Michael McDonnell, Chief Financial Officer; and Alphonse Galdes, Head of Pharmaceutical Operations and Technology; Ginger

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot